secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inari Medical, Inc. (—)
CIK:        0001531048
Form:       8-K/A
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001531048-24-000009
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 9.01, 2.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Inari Medical closes LimFlow acquisition; LimFlow reports €20.3M net loss on €938K revenue for 9 months ended Sep 2023
--------------------------------------------------------------------------------

- Acquired LimFlow, developer of TADV system for no-option CLTI patients; deal value undisclosed, announced Oct 2023.
- LimFlow's audited financials: €20.3M net loss on €938K revenue (nine months through Sep 30, 2023); €18.8M loss on €252K revenue (FY 2022).
- As of Sep 30, 2023, LimFlow had €3.1M cash, €1.5M total debt, and accumulated deficit of €101.3M.
- Inari filed pro forma combined financials reflecting the acquisition; no additional guidance on future earnings impact provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531048/000153104824000009/0001531048-24-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531048/000153104824000009/nari-20231115.htm
  HTML page:      https://secwatch.observer/filing/0001531048-24-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer